Wellspring Ophthalmics Redceives 2nd Patent for Cyclosporine Dry Eye Therapy
20 Jul 2022 //
BUSINESSWIRE
Wellspring Ophthalmics Acquires Cyclosporine Dry Eye Therapy Patent Portfolio
23 Mar 2022 //
BUSINESSWIRE
Wellspring`s Announces Clearance of IND Application to Ph1 Trial of KRAS G12C
16 May 2019 //
PR NEWSWIRE